ABL Bio Inc
KOSDAQ:298380
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
ABL Bio Inc
KOSDAQ:298380
|
KR |
|
Acutus Medical Inc
OTC:AFIB
|
US |
|
Unisync Corp
TSX:UNI
|
CA |
|
Adeia Inc
NASDAQ:ADEA
|
US |
|
Babylon Holdings Ltd
OTC:BBLNF
|
US |
|
B
|
BurTech Acquisition Corp
NASDAQ:BRKH
|
US |
|
Naturhouse Health SA
F:2NH
|
ES |
|
Gilead Sciences Inc
NASDAQ:GILD
|
US |
|
Alliance Media Holdings Inc
OTC:ADTR
|
US |
|
Kuke Music Holding Ltd
NYSE:KUKE
|
CN |
|
T
|
Translational Development Acquisition Corp
NASDAQ:TDAC
|
US |
|
W
|
WoojinNTec Inc
KOSDAQ:457550
|
KR |
|
F
|
FutureChem Co Ltd
KOSDAQ:220100
|
KR |
|
Dynacor Gold Mines Inc
TSX:DNG
|
CA |
|
Centrepoint Alliance Ltd
ASX:CAF
|
AU |
|
Bigben Interactive SA
PAR:BIG
|
FR |
|
Vection Technologies Ltd
ASX:VR1
|
AU |
|
Aegis Brands Inc
TSX:AEG
|
CA |
|
Union Gas Holdings Ltd
SGX:1F2
|
SG |
|
PDD Holdings Inc
NASDAQ:PDD
|
CN |
|
T
|
Telesat Corp
NASDAQ:TSAT
|
CA |
|
ODP Corp
NASDAQ:ODP
|
US |
|
Merko Ehitus AS
F:MKS
|
EE |
|
Monro Inc
NASDAQ:MNRO
|
US |
Wall Street
Price Targets
Price Targets Summary
ABL Bio Inc
According to Wall Street analysts, the average 1-year price target for ABL Bio Inc is 209 780 KRW with a low forecast of 77 770 KRW and a high forecast of 294 000 KRW.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is ABL Bio Inc's stock price target?
Price Target
209 780
KRW
According to Wall Street analysts, the average 1-year price target for ABL Bio Inc is 209 780 KRW with a low forecast of 77 770 KRW and a high forecast of 294 000 KRW.
What is ABL Bio Inc's Revenue forecast?
Projected CAGR
-4%
For the last 8 years the compound annual growth rate for ABL Bio Inc's revenue is 140%. The projected CAGR for the next 3 years is -4%.
